"Sadly, most stock options traders will never experience the esoteric nature of our PEETA."
........ ........ ...Capitalist Pig Bob,....
........."I am Fat Money."
http://psychologyofthecall.blogspot.com
Emails to: Psychologyofthecall@gmail.com
Wednesday, May 28, 2014
Post Earnings Educational Trade Alert (PEETA) Strategy, Pig Bob~
........ ........ ...Capitalist Pig Bob,....
........."I am Fat Money."
http://psychologyofthecall.blogspot.com
Emails to: Psychologyofthecall@gmail.com
Monday, May 26, 2014
The U.S. Soldier puts 'Life' in Perspective on Memorial Day
If not for the men and women who served the United States and Allied forces during Wartime, we would not have the privilege to trade stock options or use shallow social mediums like Facebook and Twitter..
We may have to Rise-Up again to ensure no soldier died in vain. The free-market system must thrive again as there is no better proven Economic model ever.
May God bless every man, woman, and the family members of every U.S. and Allied soldier who served, were wounded, but especially those who Died fighting for Liberty and Freedom.
Highest Regards, Hurrah!
POTC-
Sunday, May 18, 2014
Foundation Medicine and Collaborators to Present New Clinical Data on FoundationOne® and FoundationOne Heme at the 2014 ASCO Annual Meeting
Date & Time: Saturday, May 31, 2014 from 8:00 a.m. to 11:45 a.m. CT
Title: Comprehensive genomic profiling of gallbladder adenocarcinoma and frequent genomic-derived targets of therapy
Presenter: Juliann Chmielecki, Ph.D.
Title: BATTLE-2: KRAS mutation and outcome in a biomarker-integrated study in previously treated patients (pts) with advanced non-small cell lung cancer (NSCLC)
Presenter: Vassiliki Papadimitrakopoulou, M.D.
Collaborator: The University of Texas MD Anderson Cancer Center
Date & Time: Saturday, May 31, 2014 from 1:15 pm. to 5:00 p.m. CT
Title: Identifying ALK rearrangements that are not detected by FISH with targeted next-generation sequencing of lung carcinoma
Presenter: Siraj M. Ali, M.D., Ph.D.
Title: Effect of clinical NGS-based cancer genomic profiling on physician treatment decisions in advanced solid tumors
Presenter: Fadi S. Braiteh, M.D.
Collaborator: Comprehensive Cancer Centers of Nevada
Date & Time: Saturday, May 31, 2014 from 1:15 p.m. to 5:00 p.m. CT
Title: Targeted next-generation sequencing (NGS) of carcinoma of unknown primary site (CUP): Actionable genomic alterations
(GA) and new routes to targeted therapies
Presenter: Jeffrey S. Ross, M.D.
Date & Time: Sunday, June 1, 2014 from 8:00 a.m. to 11:45 a.m. CT
Title: PI3K/AKT/mTOR genomic alterations in 94 patients with metastatic breast cancer in the Phase I clinic at MD Anderson:
Prevalence and association with response
Presenter: Jennifer J. Wheler, M.D.
Collaborator: The University of Texas MD Anderson Cancer Center
Date & Time: Monday, June 2, 2014 from 8:00 a.m. to 11:45 a.m. CT
Title: Clinical application of comprehensive next-generation sequencing-based genomic profiling for identification of actionable
genomic alterations in pediatric solid tumors and hematolymphoid malignancies: The Foundation Medicine pediatric experience
Presenter: Matthew J. Hawryluk, Ph.D.
Date & Time: Monday, June 2, 2014 from 8:00 a.m. to 11:00 a.m. CT
Title: Next-generation sequencing (NGS)-based profiling of pancreatic acinar cell carcinoma for identification of a recurrent
SND1-BRAF fusion
Presenter: Juliann Chmielecki, Ph.D.
Date & Time: Monday, June 2, 2014 from 8:00 a.m. to 11:45 a.m. CT
Title: Evidence of PIK3CA and TP53 co-mutation in breast cancer identification on next-generation sequencing (NGS) of ERBB2
(HER2)-amplified residual disease following preoperative anti-HER2 therapy
Presenter: Frankie Ann Holmes, M.D.
Collaborator: Texas Oncology
Date & Time: Monday, June 2, 2014 from 8:00 a.m. to 11:45 a.m. CT
Title: Estrogen receptor-positive (ER+) metastatic breast cancer (MBC) patients (pts) with extreme responses (ERs) to
capecitabine having tumors with genomic alterations in DNA repair and chromatin remodeling genes
Presenter: Joyce O'Shaughnessy, M.D.
Collaborator: Texas Oncology-Baylor Charles A. Sammons Cancer Center
Date & Time: Monday, June 2, 2014 from 8:00 a.m. to 11:00 a.m. CT
Title: Analysis of candidate homologous repair deficiency genes in a clinical trial of olaparib in patients with platinum-sensitive, relapsed serous ovarian cancer (PSR SOC).
Presenter: Jonathan Ledermann,
Collaborator: AstraZeneca
Date & Time: Monday, June 2, 2014 from 1:15 p.m. to 4:15 p.m. CT
Title: Next-generation sequencing (NGS) in relapsed/refractory triple-negative breast cancer (TNBC) in Israel
Session: Poster Highlights Session
Presenter: Noa Ben-Baruch, M.D.
Collaborator: Teva Pharmaceuticals
Date & Time: Monday, June 2, 2014 from 1:15 p.m. to 5:00 p.m. CT
Title: Next-generation sequencing to identify molecular alterations in DNA repair and chromatin maintenance genes associated with pathologic complete response (pT0) to neoadjuvant accelerated methotrexate, vinblastine, doxorubicin, and cisplatin
(AMVAC) in muscle-invasive bladder cancer (MIBC)
Presenter: Elizabeth R. Plimack, M.D., M.S.
Collaborator: Fox Chase Cancer Center
Date & Time: Monday, June 2, 2014 from 2:03 p.m. to 2:15 p.m. CT
Title: Whole-exome and targeted sequencing of angiosarcomas: Target identification and treatment implications
Session: Clinical Science Symposium
Presenter: Vinod Ravi, M.D.
Collaborator: The University of Texas MD Anderson Cancer Center
Date & Time: Monday, June 2, 2014 from 5:24 p.m. to 5:36 p.m. CT
Title: Comprehensive genomic profiling of solid tumors from 677 adolescents and young adults for revealing a distinct spectrum of targetable genomic alterations
Session: Oral Abstract Session
Presenter: Brandon Hayes-Lattin, M.D.
Date & Time: Tuesday, June 3, 2014 from 8:00 a.m. to 11:00 a.m. CT
Title: Rictor amplification to define a novel and unique subset of lung cancer patients
Presenter: Haiying Cheng, M.D., Ph.D.
Collaborator: Columbia University Medical Center
Date & Time: Tuesday, June 3, 2014 from 8:00 a.m. to 11:00 a.m. CT
Title: Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in "pan-negative" lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history
Presenter: Alexander E. Drilon, M.D.
Collaborator: Memorial Sloan-Kettering Cancer Center
We organized this piece to be more helpful than the one on the official ASCO website,
POTC-
http://psychologyofthecall.blogspot.com
Saturday, May 17, 2014
Monday, May 5, 2014
China's Shanghai Rallies despite a Contraction in Manufacturing
The Purchasers Managers Index (PMI) in China for April fell to 48.1 from 48.3. The survey showed factory activity in the world's 2nd largest economy contracting for a 4th consecutive month, yet the Shanghai shrugged it off.
Most U.S. money managers are keeping an eye on China. If the Shanghai adds 1% or more on Tuesday than Monday's late rally could signal that the Govt is prepared to act with measures that would quell fears and spark a longer-term move higher in stocks.
Maybe the Year of the Horse will prove to have more bucking power than many bears now estimate.
Thank You,
POTC-
http://psychologyofthecall.blogspot.com
Monday's late rally was impressive from both a Price and Volume standpoint
Shanghai composite since the 1990's reveals the Key 2,000 level of Support
Most U.S. money managers are keeping an eye on China. If the Shanghai adds 1% or more on Tuesday than Monday's late rally could signal that the Govt is prepared to act with measures that would quell fears and spark a longer-term move higher in stocks.
Maybe the Year of the Horse will prove to have more bucking power than many bears now estimate.
Thank You,
POTC-
http://psychologyofthecall.blogspot.com
Saturday, May 3, 2014
With Real US Unemployment above 12%, Pig Bob thinks it's Time for Buffett and Munger to Retire and Hire some Younger Blood..
Anyone?
Subscribe to:
Posts (Atom)